Retraction: Aberrant expression of B7‑H3 in gastric adenocarcinoma promotes cancer cell metastasis (Oncol Rep (2014) 32: (2086‑2092) DOI: 10.3892/or.2014.3405);Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis

Oncology Reports

Volumn 32, Issue 5, 2014, Pages 2086-2092

  Dai, Wei ^a   Shen, Genhai ^a   Qiu, Jianping ^a   Zhao, Xin ^b   Gao, Quangen ^a  

^a First People's Hospital of Wujiang   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

B7 H3; Gastric cancer; Metastasis

Indexed keywords

LYMPHOCYTE ANTIGEN; PROTEIN B7 H3; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; B7 ANTIGEN; CD276 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GASTRIC CANCER CELL LINE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; STOMACH ADENOCARCINOMA; TUMOR PROMOTION; TUMOR VOLUME; VISCERAL METASTASIS; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; B7 ANTIGENS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; STOMACH NEOPLASMS;

EID: 84907287777     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2022.8421     Document Type: Erratum

References (32)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Suh WK, Wang SX, Jheon AH, et al: The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci USA 101: 12969-12973, 2004.
3. Steinberger P, Majdic O, Derdak SV, et al: Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol 172: 2352-2359, 2004.
4. Zhang GB, Zhou H, Chen YJ, et al: Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells. Tissue Antigens 66: 83-92, 2005.
5. Yamato I, Sho M, Nomi T, et al: Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 101: 1709-1716, 2009.
6. Chapoval AI, Ni J, Lau JS, et al: B7-H3: a costimulatory molecule for T cell activation and IFN-γ production. Nat Immunol 2: 269-274, 2001.
7. Luo L, Chapoval AI, Flies DB, et al: B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells. J Immunol 173: 5445-5450, 2004.
8. Lupu CM, Eisenbach C, Kuefner MA, et al: An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo. J Gastrointest Surg 10: 635-645, 2006.
9. Castriconi R, Dondero A, Augugliaro R, et al: Identification of 4Ig-B7-H3 as a neuroblastoma associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc Natl Acad Sci USA 101: 12640-12645, 2004.
10. Suh WK, Gajewska BU, Okada H, et al: The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 4: 899-906, 2003.
11. Prasad DV, Nguyen T, Li Z, et al: Murine B7-H3 is a negative regulator of T cells. J Immunol 173: 2500-2506, 2004.
12. Fukushima A, Sumi T, Fukuda K, et al: B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol Lett 113: 52-57, 2007.
13. Ghadially R: The role of stem and circulating cells in cancer metastasis. J Surg Oncol 103: 555-557, 2011.
14. Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
15. Chen YW, Tekle C and Fodstad O: The immunoregulatory protein human B7-H3 is a tumor-Associated antigen that regulates tumor cell migration and invasion. Curr Cancer Drug Targets 8: 404-413, 2008.
16. Zhang G, Hou J, Shi J, et al: Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology 123: 538-546, 2008.
17. Zhao X, Li DC, Zhu XG, et al: B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med 31: 283-291, 2013.
18. Tsai CY, Lee TS, Kou YR and Wu YL: Glucosamine inhibits IL-1β-mediated IL-8 production in prostate cancer cells by MAPK attenuation. J Cell Biochem 108: 489-498, 2009.
19. Fernandez-Martinez AB, Bajo AM, Sanchez-Chapado M, et al: Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells. Prostate 69: 774-786, 2009.
20. Yaqinuddin A, Qureshi SA, Qazi R, et al: DNM T1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness. J Urol 182: 756-761, 2009.
21. ElBayoumi TA and Torchilin VP: Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long.circulating liposomes modified with cancer-specific monoclonal antibody. Clin Cancer Res 15: 1973-1980, 2009.
22. Dong H, Zhu G, Tamada K, et al: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5: 1365-1369, 1999.
23. Wang S, Zhu G, Chapoval AI, et al: Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96: 2808-2813, 2000.
24. Sica GL, Choi IH, Zhu G, et al: B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18: 849-861, 2003.
25. Tseng SY, Otsuji M, Gorski K, et al: B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193: 839-846, 2001.
26. Brandt CS, Baratin M, Yi EC, et al: The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206: 1495-1503, 2009.
27. Wu CP, Jiang JT, Tan M, et al: Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 12: 457-459, 2006.
28. Zhang G, Xu Y, Lu X, et al: Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer 66: 245-249, 2009.
29. Sun J, Mao Y, Zhang YQ, et al: Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7.H3 in human non.small cell lung cancer. Oncol Lett 6: 1253-1260, 2013.
30. Qin X, Zhang H, Ye D, et al: B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma. Onco Targets Ther 6: 1667-1673, 2013.
31. Yang QS, Gu JL, Du LQ, et al: ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to γ-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines. J Radiat Res 49: 399-407, 2008.
32. Zhao J, Lei T, Xu C, et al: MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3. Biochem Biophys Res Commun 438: 439-444, 2013.